Inspire Medical (Germany) Performance
| 2DR Stock | EUR 180.25 2.10 1.15% |
The company retains a Market Volatility (i.e., Beta) of -0.032, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Inspire Medical are expected to decrease at a much lower rate. During the bear market, Inspire Medical is likely to outperform the market. At this point, Inspire Medical Systems has a negative expected return of -0.0132%. Please make sure to check out Inspire Medical's treynor ratio, value at risk, and the relationship between the total risk alpha and maximum drawdown , to decide if Inspire Medical Systems performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Inspire Medical Systems has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Inspire Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 214.5 M |
Inspire |
Inspire Medical Relative Risk vs. Return Landscape
If you would invest 18,475 in Inspire Medical Systems on October 6, 2024 and sell it today you would lose (450.00) from holding Inspire Medical Systems or give up 2.44% of portfolio value over 90 days. Inspire Medical Systems is currently producing negative expected returns and takes up 2.3431% volatility of returns over 90 trading days. Put another way, 20% of traded stocks are less volatile than Inspire, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Inspire Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Inspire Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Inspire Medical Systems, and traders can use it to determine the average amount a Inspire Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0056
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 2DR |
Estimated Market Risk
| 2.34 actual daily | 20 80% of assets are more volatile |
Expected Return
| -0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Inspire Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inspire Medical by adding Inspire Medical to a well-diversified portfolio.
Inspire Medical Fundamentals Growth
Inspire Stock prices reflect investors' perceptions of the future prospects and financial health of Inspire Medical, and Inspire Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Inspire Stock performance.
| Return On Equity | -0.12 | |||
| Return On Asset | -0.0692 | |||
| Profit Margin | (0.11) % | |||
| Operating Margin | (0.12) % | |||
| Current Valuation | 6.62 B | |||
| Shares Outstanding | 29.05 M | |||
| Price To Book | 15.49 X | |||
| Price To Sales | 19.86 X | |||
| Revenue | 407.86 M | |||
| EBITDA | (40.73 M) | |||
| Cash And Equivalents | 226.14 M | |||
| Cash Per Share | 8.31 X | |||
| Total Debt | 15.8 M | |||
| Debt To Equity | 0.14 % | |||
| Book Value Per Share | 17.10 X | |||
| Cash Flow From Operations | 11.57 M | |||
| Earnings Per Share | (1.53) X | |||
| Total Asset | 564.88 M | |||
About Inspire Medical Performance
By analyzing Inspire Medical's fundamental ratios, stakeholders can gain valuable insights into Inspire Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Inspire Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Inspire Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea in the United States and Europe. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. INSPIRE MED operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 341 people.Things to note about Inspire Medical Systems performance evaluation
Checking the ongoing alerts about Inspire Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Inspire Medical Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Inspire Medical generated a negative expected return over the last 90 days | |
| The company reported the revenue of 407.86 M. Net Loss for the year was (44.88 M) with profit before overhead, payroll, taxes, and interest of 341.74 M. | |
| Over 99.0% of the company shares are owned by institutions such as pension funds |
- Analyzing Inspire Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Inspire Medical's stock is overvalued or undervalued compared to its peers.
- Examining Inspire Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Inspire Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Inspire Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Inspire Medical's stock. These opinions can provide insight into Inspire Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Inspire Stock analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |